Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Eplerenone	26
Overall Study	STARTED	Spironolactone	26
Overall Study	2 Weeks	Eplerenone	26
Overall Study	2 Weeks	Spironolactone	25
Overall Study	1 Month	Eplerenone	24
Overall Study	1 Month	Spironolactone	23
Overall Study	2 Months	Eplerenone	24
Overall Study	2 Months	Spironolactone	22
Overall Study	3 Months	Eplerenone	25
Overall Study	3 Months	Spironolactone	23
Overall Study	6 Months	Eplerenone	25
Overall Study	6 Months	Spironolactone	23
Overall Study	9 Months	Eplerenone	25
Overall Study	9 Months	Spironolactone	23
Overall Study	COMPLETED	Eplerenone	23
Overall Study	COMPLETED	Spironolactone	23
Overall Study	NOT COMPLETED	Eplerenone	3
Overall Study	NOT COMPLETED	Spironolactone	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02354352/flow